|
|
.
See Category: Neoplasms
See Header: Benign neoplasm of short bones of lower limb
ICD-10 (CM) Code and Descriptor
|
D16.31 |
Benign neoplasm of short bones of right lower limb
|
D1631 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 9 |
ICD10
Position 10 |
ICD10
Position 11 |
| 45.56%
|
27.04%
|
11.85%
|
5.19%
|
4.44%
|
0.74%
|
1.48%
|
0.74%
|
1.11%
|
0.37%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D16.31*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J2704
|
INJ, PROPOFOL, 10 MG |
57
|
1,812
|
|
J3010
|
FENTANYL CITRATE INJECTION |
50
|
62
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
40
|
151
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
37
|
98
|
|
J2405
|
ONDANSETRON HCL INJECTION |
37
|
146
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
32
|
230
|
|
88311
|
DECALCIFY TISSUE |
30
|
31
|
|
73630
|
X-RAY EXAM OF FOOT |
30
|
30
|
|
J7120
|
RINGERS LACTATE INFUSION |
26
|
29
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
20
|
20
|
|
28104
|
REMOVAL OF FOOT LESION |
15
|
15
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
14
|
27
|
|
J2001
|
LIDOCAINE INJECTION |
14
|
71
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
13
|
15
|
|
82962
|
GLUCOSE BLOOD TEST |
12
|
14
|
|
28108
|
REMOVAL OF TOE LESIONS |
12
|
12
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
12
|
18
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
11
|
11
|
|
28124
|
PARTIAL REMOVAL OF TOE |
11
|
11
|
|
73620
|
X-RAY EXAM OF FOOT |
11
|
11
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D16.31 related to the following DRG Codes:
564-566
|
